Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BHFAN vs JXN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

JXN Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 6–4 Matrix Metrics)

JXN Overall Winner 6-Pillar Tally: BHFAN 1 – 5 JXN Matrix Metrics: BHFAN 4 – 6 JXN

As of Nov 20, 2026, Jackson Financial Inc. (JXN) is the stronger overall head-to-head candidate over Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). BHFAN carries a Unified Composite Score of 33.7/100 (SELL) at $9.18 (N/M Forward P/E, 18.4% operating margin), whereas JXN carries 45.5/100 (HOLD) at $127.12 (3.9x Forward P/E, 6.3% operating margin).

  • Technical & Structure Timing Caution: BHFAN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.9); meanwhile JXN trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 37.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BHFAN vs JXN
BHFAN NASDAQ
Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C
Life Insurance
$9.18
-0.65% 1D
Market Cap N/A
TTM Revenue $5.81B
Forward P/E N/M
Beta / 30D Vol 0.36β · 16% Vol
Unified Composite Score
33.7 / 100 SELL
Tech 18.0 Fund 37.0 Flow 50.0 Mom 49.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.0%), weak momentum, RSI 18
RSI-14: 17.9 · SMA20: $10.09 · SMA50: $10.65
JXN NYSE Head-to-Head Winner
Jackson Financial Inc.
Life Insurance
$127.12
-1.88% 1D
Market Cap $8.6B
TTM Revenue $6.67B
Forward P/E 3.9x
Beta / 30D Vol 0.74β · 29% Vol
Unified Composite Score
45.5 / 100 HOLD
Tech 34.0 Fund 49.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 37
RSI-14: 37.3 · SMA20: $135.19 · SMA50: $133.10

6-Pillar Scorecard Institutional Category Breakdown (BHFAN 1 – 5 JXN)

Columns: Metric · BHFAN · JXN
1. Valuation Multiples JXN
Forward P/E N/M 3.9x
Trailing P/E 0.7x 10.6x
PEG Ratio N/M N/M
EV / Revenue N/M 1.5x
2. Growth & Scale JXN
Revenue Growth (YoY) -52.7% +8.6%
Earnings Growth (YoY) -34.0% N/A
TTM Revenue (USD) $5.81B $6.67B
Market Cap N/A $8.6B
3. Profitability & Quality BHFAN
Gross Margin 16.5% 49.2%
Operating Margin 18.4% 6.3%
Net Profit Margin 11.7% 13.3%
Return on Equity (ROE) 11.9% 9.5%
4. Balance Sheet & Cash Flow JXN
Cash Generation (TTM) N/A $5.93B
Cash Flow Margin N/A 89.0%
Net Cash / Leverage $87.13 Book/Sh · 11.9% ROE $1.13B Net Debt (0.62x D/E)
Dividend Yield 14.25% 2.64%
5. Options & Positioning JXN
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 42.2% (11th %ile)
Put/Call OI Skew N/A 4.97x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat JXN
OpEx & R&D Intensity N/A 42.9% of Rev ($2.86B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance - Life Operator Insurance - Life Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BHFAN (4) vs JXN (6)
Institutional Metric BHFAN JXN Criterion Row Edge
Market Capitalization
Scale
N/A $8.6B Larger Scale JXN
Trailing P/E Ratio
Valuation
0.7x 10.6x Lower Multiple BHFAN
Forward P/E Ratio
Valuation
N/M 3.9x Lower Multiple JXN
Revenue Growth (YoY)
Growth
-52.7% +8.6% Higher Growth JXN
Operating Margin (TTM)
Profitability
18.4% 6.3% Higher Margin BHFAN
Net Profit Margin
Profitability
11.7% 13.3% Higher Margin JXN
Return on Equity (ROE)
Capital Efficiency
11.9% 9.5% Higher ROE BHFAN
52-Week Range Position
Momentum
0% ($9–$14) 61% ($91–$150) Stronger Trend JXN
Beta / 30D Volatility
Risk Regime
0.36β · 16% Vol 0.74β · 29% Vol Lower Realized Risk BHFAN
Unified Institutional Score
Composite Signal
33.7 / 100 (SELL) 45.5 / 100 (HOLD) Higher Composite JXN
Trailing 12M Revenue (USD)
Operating Scale
$5.81B $6.67B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
16.5% 49.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 1.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($87.13 Book/Sh · 11.9% ROE) $5.93B ($1.13B Net Debt (0.62x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon JXN +7.59 pp
BHFAN: -12.24% · JXN: -4.65%
3M Horizon JXN +17.47 pp
BHFAN: -21.4% · JXN: -3.93%
6M Horizon JXN +45.71 pp
BHFAN: -26.85% · JXN: +18.86%
1Y Horizon JXN +66.26 pp
BHFAN: -29.0% · JXN: +37.26%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHFAN vs JXN. Trailing 12-month operating profitability (BHFAN 18.4% vs JXN 6.3%) and valuation multiples (BHFAN N/M vs JXN 3.9x Forward P/E) are benchmarked directly in Pillar 4 below.

BHFAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.81B
Gross Margin16.5%
Op. Margin18.4%
ROE / Fwd P/E11.9% · N/M
JXN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$6.67B
Gross Margin49.2%
Op. Margin6.3%
ROE / Fwd P/E9.5% · 3.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BHFAN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHFAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
JXN CONSOLIDATION
54d in phase · OBV DISTRIBUTION
Current IV 42.2%
IV Percentile 11th %ile
Put/Call OI Skew 4.97x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact JXN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $137.59 · IV 33.6%

JXN Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($13,759)

Compare $13,759 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 33.6% ATM IV.

5-DAY BULLISH SWING Liq B

Dec 18 $135 / $145 Bull Call Spread

Buy 1x $135C · Sell 1x $145C · 32d

Net Entry $425 Debit
T+5d @ +5% Move +$217 (+51%)
Max Risk / Buffer $425 Capped
5d Edge & Liquidity 0.9x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $130 / $125 Bull Put Spread

Sell 1x $130P · Buy 1x $125P · 32d

Net Entry $105 Credit
Max Credit / Yield +$105 (+26.6% RoM)
Max Risk / Buffer -6.3% Cushion ($395 Mgn)
5d Edge & Liquidity 72% PoP · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BHFAN Moat Profile Scale & Operating Efficiency Moat
Insurance - Life Operator
Competes within the Insurance - Life value chain with N/A market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
JXN Moat Profile Cyclical / Execution-Driven Positioning
Insurance - Life Operator
Competes within the Insurance - Life value chain with $8.6B market capitalization and 6.3% operating margin.
OpEx & R&D Reinvestment 42.9% of Rev ($2.86B)
90D Engineering Disclosures 0 Published

Investor FAQ BHFAN vs JXN Key Questions & Quantitative Answers

As of Nov 20, 2026, Jackson Financial Inc. (JXN) is the stronger overall head-to-head candidate over Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). BHFAN carries a Unified Composite Score of 33.7/100 (SELL) at $9.18 (N/M Forward P/E, 18.4% operating margin), whereas JXN carries 45.5/100 (HOLD) at $127.12 (3.9x Forward P/E, 6.3% operating margin). Technical & Structure Timing Caution: BHFAN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.9); meanwhile JXN trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 37.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

JXN leads the Growth & Scale pillar: BHFAN posts -52.7% YoY revenue growth and -34.0% YoY earnings growth on $5.81B TTM revenue (16.5% gross margin, 18.4% operating margin), compared with JXN at +8.6% YoY revenue growth and N/A YoY earnings growth on $6.67B TTM revenue (49.2% gross margin, 6.3% operating margin). On trailing 12-month operating scale, BHFAN generates $5.81B in USD-normalized revenue versus $6.67B for JXN. In operating R&D and SG&A reinvestment, BHFAN deploys N/A (0 90-day corporate R&D disclosures) versus 42.9% of Rev ($2.86B) (0 disclosures) for JXN.

JXN screens cheaper on headline valuation multiples. BHFAN trades at N/M Forward P/E, 0.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas JXN trades at 3.9x Forward P/E, 10.6x Trailing P/E, N/M PEG, and 1.5x EV/Revenue (89.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHFAN (11.9% ROE) versus JXN (9.5% ROE) capital efficiency.

In options market volatility and institutional positioning, BHFAN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.36β · 16% Vol realized risk). By comparison, JXN carries 42.2% implied volatility (11th %ile, Compressed (<25th %ile)), a 4.97x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.74β · 29% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.